These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24286154)

  • 1. Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
    Bansal S; Blalock D; Kebede T; Dean NP; Carpenter JL
    J Neurosurg Pediatr; 2014 Feb; 13(2):209-15. PubMed ID: 24286154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage.
    Taylor S; Heinrichs RJ; Janzen JM; Ehtisham A
    Neurocrit Care; 2011 Aug; 15(1):80-4. PubMed ID: 20890680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
    Yang Y; Zheng F; Xu X; Wang X
    CNS Drugs; 2016 Aug; 30(8):677-88. PubMed ID: 27395404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizures in patients with glioma treated with phenytoin and levetiracetam.
    Merrell RT; Anderson SK; Meyer FB; Lachance DH
    J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.
    Floeter AE; McCune JS
    J Oncol Pharm Pract; 2017 Jul; 23(5):344-349. PubMed ID: 27208016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of levetiracetam versus phenytoin for seizure prophylaxis after traumatic brain injury: A systematic review and meta-analysis.
    Xu JC; Shen J; Shao WZ; Tang LJ; Sun YZ; Zhai XF; Qi L; Li J; Zheng JY
    Brain Inj; 2016; 30(9):1054-61. PubMed ID: 27295203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.
    Iuchi T; Kuwabara K; Matsumoto M; Kawasaki K; Hasegawa Y; Sakaida T
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1158-62. PubMed ID: 25511789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution.
    Hughes K; Garrity L; Nelson AS; Lane A; Teusink-Cross A
    Pediatr Transplant; 2021 Jun; 25(4):e14026. PubMed ID: 33894096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam Prophylaxis for Post-traumatic Brain Injury Seizures is Ineffective: A Propensity Score Analysis.
    Zangbar B; Khalil M; Gruessner A; Joseph B; Friese R; Kulvatunyou N; Wynne J; Latifi R; Rhee P; O'Keeffe T
    World J Surg; 2016 Nov; 40(11):2667-2672. PubMed ID: 27307089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
    Szaflarski JP; Sangha KS; Lindsell CJ; Shutter LA
    Neurocrit Care; 2010 Apr; 12(2):165-72. PubMed ID: 19898966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury.
    Gabriel WM; Rowe AS
    Ann Pharmacother; 2014 Nov; 48(11):1440-4. PubMed ID: 25169249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Early Posttraumatic Seizures in Children With Moderate to Severe Traumatic Brain Injury Despite Levetiracetam Prophylaxis.
    Chung MG; O'Brien NF
    Pediatr Crit Care Med; 2016 Feb; 17(2):150-6. PubMed ID: 26669640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
    Cotton BA; Kao LS; Kozar R; Holcomb JB
    J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis.
    Radic JA; Chou SH; Du R; Lee JW
    Neurocrit Care; 2014 Oct; 21(2):228-37. PubMed ID: 24549935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.
    Kruer RM; Harris LH; Goodwin H; Kornbluth J; Thomas KP; Slater LA; Haut ER
    J Crit Care; 2013 Oct; 28(5):883.e9-13. PubMed ID: 23566730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Köle MT; Sager SG; Zeynel H; Çağ Y; Akın Y
    Childs Nerv Syst; 2022 Jul; 38(7):1357-1364. PubMed ID: 35501510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.
    Pourzitaki C; Tsaousi G; Apostolidou E; Karakoulas K; Kouvelas D; Amaniti E
    Br J Clin Pharmacol; 2016 Jul; 82(1):315-25. PubMed ID: 26945547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation.
    Soni S; Skeens M; Termuhlen AM; Bajwa RP; Gross TG; Pai V
    Pediatr Blood Cancer; 2012 Oct; 59(4):762-4. PubMed ID: 22378696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.